Comparison of 8 weeks standard treatment (rifampicin plus clarithromycin) vs. 4 weeks standard plus amoxicillin/clavulanate treatment [RC8 vs. RCA4] to shorten Buruli ulcer disease therapy (the BLMs4BU trial): study protocol for a randomized controlled multi-centre trial in Benin.
Trials
; 23(1): 559, 2022 Jul 08.
Article
in En
| MEDLINE
| ID: mdl-35804454
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Buruli Ulcer
/
Anti-Bacterial Agents
Type of study:
Clinical_trials
/
Guideline
/
Prognostic_studies
Limits:
Humans
Country/Region as subject:
Africa
Language:
En
Journal:
Trials
Journal subject:
MEDICINA
/
TERAPEUTICA
Year:
2022
Document type:
Article
Affiliation country:
Country of publication: